Loading...
SLVM is not a good buy right now for an impatient investor. The tape is still bearish (price below pivot with negative/expanding MACD), the short-term pattern/probability skew points to further downside, and the latest quarter showed clear YoY deterioration in revenue, earnings, and margins. While the stock is near support and looks oversold (potential bounce setup), there is no Intellectia buy signal today and options volume is put-heavy, so the risk/reward for an immediate entry is unfavorable.
Trend/price action: SLVM is down -3.16% to 48.41 while the S&P 500 is down -0.45%, showing relative weakness today.
Momentum: MACD histogram is -0.326 (below zero) and negatively expanding → bearish momentum is strengthening. RSI(6): 25.59 → this is typically oversold, which can support a short-term bounce, but oversold can persist in a down-move.
Levels: Pivot 50.342 is overhead (bulls need to reclaim this to improve trend). Near-term support is S1 48.593 (price is slightly below it at 48.41), then S2 47.512. Resistance levels: R1 52.092, R2 53.173.
Pattern-based outlook (provided): 60% probability of -3.08% next day, -4.22% next week, -2.65% next month → statistical bias remains to the downside.
Intellectia Proprietary Trading Signals

near oversold levels and price is near the 47.5–48.6 support zone, which can produce a reflex bounce.
suggests some investors are still positioned for upside.
on 2026-02-12 pre-market could be a catalyst if results/guide beat low expectations (EPS est. 1.05).
and just broke under S1 (48.
→ downside pressure still active.
signals near-term caution and hedging/speculation to the downside.
Latest quarter: 2025/Q3. Growth trends (YoY): Revenue 846M (-12.33%), Net Income 57M (-40.00%), EPS 1.41 (-37.89%), Gross Margin 20.45% (-12.68%). Takeaway: This is a clear negative growth/margin trend, consistent with a tougher demand/pricing environment; it weakens the case for an immediate buy until momentum stabilizes or earnings show re-acceleration.
Recent rating/target trend: Sentiment improved into late 2025 with BofA upgrading SLVM to Buy (from Underperform) on 2025-11-17 and lifting PT to $59 (from $41). After that, targets moved modestly: RBC raised PT to $49 (Sector Perform) on 2025-11-10 and then to $53 on 2025-12-18; BofA trimmed PT slightly to $57 on 2026-01-05 while keeping Buy.
Wall Street pros: Low-cost mill system, ongoing cost competitiveness efforts, and shareholder returns are viewed positively. Wall Street cons: Challenging Europe outlook, tepid demand conditions, and risk from imports into North America. Overall: mixed-to-cautiously constructive, but not signaling urgency to buy at this moment.
Influential/politician activity: No recent congress trading data available; hedge fund and insider trends are neutral (no significant recent activity).